Annual Report

Overview

The report describes the company's 2021 ESG performance for its PRC pharmaceutical distribution operations, excluding Hong Kong as insignificant to overall Group operations. The Board oversees ESG strategy through an ESG team, and stakeholders participated in a materiality assessment. Reported environmental metrics include a 95.4tCO2e carbon footprint, 177.3 kWh total energy consumption, and 686.3 m3 total water consumption.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2021
Period: 1 January 2021 – 31 December 2021
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services